U.S. Physical Therapy, Inc. (NYSE:USPH) Director Clayton Trier sold 4,250 shares of the company’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $71.97, for a total value of $305,872.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) traded down $0.15 on Tuesday, reaching $71.05. The company had a trading volume of 48,200 shares, compared to its average volume of 57,177. The stock has a market cap of $895.78, a PE ratio of 34.40, a price-to-earnings-growth ratio of 3.06 and a beta of 1.08. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.04 and a quick ratio of 2.04. U.S. Physical Therapy, Inc. has a twelve month low of $56.50 and a twelve month high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, November 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). The company had revenue of $103.03 million for the quarter, compared to analysts’ expectations of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. research analysts predict that U.S. Physical Therapy, Inc. will post 2.07 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 8th. Investors of record on Friday, November 17th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, November 16th. This represents a $0.80 dividend on an annualized basis and a yield of 1.13%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 48.19%.

A number of research analysts have recently commented on the company. BidaskClub raised U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 28th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $74.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 2nd. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $64.00 price target on the stock in a research report on Tuesday, August 29th. Sidoti raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price target for the company from $62.00 to $74.00 in a research report on Friday, September 8th. Finally, Barrington Research cut U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research report on Friday, November 3rd. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. U.S. Physical Therapy currently has an average rating of “Hold” and an average target price of $69.00.

A number of institutional investors and hedge funds have recently modified their holdings of USPH. Teachers Advisors LLC lifted its holdings in U.S. Physical Therapy by 2.4% during the 1st quarter. Teachers Advisors LLC now owns 29,647 shares of the company’s stock worth $1,936,000 after purchasing an additional 684 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in U.S. Physical Therapy by 4.9% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 53,096 shares of the company’s stock worth $3,468,000 after purchasing an additional 2,490 shares in the last quarter. State Street Corp lifted its holdings in U.S. Physical Therapy by 3.6% during the 1st quarter. State Street Corp now owns 307,662 shares of the company’s stock worth $20,093,000 after purchasing an additional 10,548 shares in the last quarter. Municipal Employees Retirement System of Michigan lifted its holdings in U.S. Physical Therapy by 3.1% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $178,000 after purchasing an additional 90 shares in the last quarter. Finally, Great West Life Assurance Co. Can lifted its holdings in U.S. Physical Therapy by 5.5% during the 2nd quarter. Great West Life Assurance Co. Can now owns 18,143 shares of the company’s stock worth $1,095,000 after purchasing an additional 950 shares in the last quarter. 99.75% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Clayton Trier Sells 4,250 Shares of U.S. Physical Therapy, Inc. (USPH) Stock” was first published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/12/clayton-trier-sells-4250-shares-of-u-s-physical-therapy-inc-usph-stock.html.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.